1359 / 1631
- In comparison with EMP, SBP has worse prognosis, with a
significantly higher risk for progression to myeloma (65-80%
in 10 years), in spite of better local control rates
|
|
1359 / 1631
- In comparison with EMP, SBP has worse prognosis, with a
significantly higher risk for progression to myeloma (65-80%
in 10 years), in spite of better local control rates